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Abstract
Bifidobacteria are claimed to contribute positively to human health through a range of beneficial or probiotic activities,
including amelioration of gastrointestinal and metabolic disorders, and therefore this particular group of gastrointestinal
commensals has enjoyed increasing industrial and scientific attention in recent years. However, the molecular mechanisms
underlying these probiotic mechanisms are still largely unknown, mainly due to the fact that molecular tools for
bifidobacteria are rather poorly developed, with many strains lacking genetic accessibility. In this work, we describe the
generation of transposon insertion mutants in two bifidobacterial strains, B. breve UCC2003 and B. breve NCFB2258. We also
report the creation of the first transposon mutant library in a bifidobacterial strain, employing B. breve UCC2003 and a Tn5-
based transposome strategy. The library was found to be composed of clones containing single transposon insertions which
appear to be randomly distributed along the genome. The usefulness of the library to perform phenotypic screenings was
confirmed through identification and analysis of mutants defective in D-galactose, D-lactose or pullulan utilization abilities.
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Introduction
Members of the genus Bifidobacterium are anaerobic Gram-
positive bacteria, constituting one of the members of Actinobac-
teria phylum that inhabit the human gastrointestinal tract (GIT)
[1], [2]. Bifidobacteria represent one of the dominant bacterial
commensals in the infant gut, where they can be present at
concentrations of 1010 cells per gram of feces, while they are less
abundant in adults and elderly people [3], [4], [5].
The probiotic concept was first introduced by Metchnikoff [6],
while probiotics are currently defined by the WHO as ‘‘live
microorganisms which when administered in adequate amounts
confer a health benefit on the host’’ [7]. A range of studies support
the idea that bifidobacteria play a significant role in maintaining
the health status of the host, by eliciting a plethora of beneficial
properties, such as immune modulation, protection against
infectious diseases, reduction of cholesterol levels, alleviation of
lactose intolerance, reducing the symptoms of inflammatory
disorders of the GIT, and production of vitamins and acetate
[8], [9], [10], [11]. Therefore, some bifidobacterial strains are
commercially exploited as probiotics (i.e. B. animalis subsp. lactis
Bb12, B. animalis subsp. lactis Bi-07 300B, Bifidobacterium animalis
subsp. lactis DN-173 010, or B. longum Bb536), being widely
included in functional foods [10], [12]. Moreover, their status as
‘‘generally recognized as safe’’ (GRAS) organisms makes them
potential candidates for the development of delivery systems to
produce peptides or proteins of interest at intestinal level as well as
for the use as live oral vaccines [13], [14], [15], [16].
During the last decade, 37 complete bifidobacterial genome
sequences have become publicly available, with an additional 14
incomplete genomes and targeted sequencing projects currently
listed on the Integrated Microbial Genomes Database (http://img.
jgi.doe.gov). These genome-scale analyses have contributed
significantly to our understanding as to how these bacteria
colonize and adapt to the human gut [17], [18], [19], [20].
Nevertheless, until recently bifidobacteria have been rather
recalcitrant to genetic manipulation, which represents one of the
main reasons for our poor understanding of the molecular
mechanisms underlying their probiotic attributes. Development
of molecular methodologies that facilitate genetic accessibility is
thus critical to allow functional genomic analyses of bifidobacteria.
In molecular biology, the gold standard method to determine
the function of predicted genes and establish which genes are
essential under particular environmental conditions is to disrupt
the gene and determine the phenotypic change. Transformation
efficiencies of individual bifidobacterial strains are generally too
low to generate targeted mutants by homologous recombination.
A well-characterized exception to this is Bifidobacterium breve
UCC2003, where this limitation was overcome by methylation
of a non-replicating plasmid to by-pass the restriction-modification
systems and to force direct and homology-directed chromosomal
integration into a targeted gene [21]. In addition, a conditionally
replicating plasmid was recently described for a bifidobacterial
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strain [22]. Although a double cross-over recombination method-
ology has been reported for a Bifidobacterium longum strain, this
procedure is tedious and highly strain dependent [23]. Remark-
ably, only targeted mutagenesis systems have been reported in
bifidobacteria and we are not aware of any random-mutagenesis
technology applicable to bifidobacteria.
Transposons are a powerful tool in molecular biology research
and have been widely used to create mutant libraries in a wide
range of genera [24], [25], [26], [27]. Such a mutant library is
highly valuable as it allows high through-put screening aimed at
the identification of genes essential for defined phenotypes [28]. In
the present study we describe the implementation of a Tn5-based
transposon mutagenesis system in two different bifidobacterial
strains, B. breve UCC2003 and B. breve NCFB2258, for which
relatively high transformation efficiencies have previously been
achieved [21], [29]. We also report the creation of a collection of
nearly 20,000 transposon insertion mutants in our model strain B.
breve UCC2003 which, to our knowledge, represents the first
genome-wide random mutagenesis approach for bifidobacteria.
Analysis of transposon insertion mutants by Southern hybridiza-
tion and sequencing of transposon insertion sites confirmed non-
biased transposon insertion events. Phenotypic screenings for
growth deficiencies in certain carbohydrates further allowed the
validation of the usefulness of this mutant bank and revealed in
most cases a direct and logical correlation between a particular
growth-deficient phenotype and the mutation of a specific gene.
Materials and Methods
Bacterial Strains and Growth Conditions
B. breve UCC2003 and B. breve NCFB2258 were grown at 37uC
in RCM (Oxoid, Hamphsire, England) or modified de Man
Rogosa and Sharpe (mMRS) medium, made from first principles
[30], supplemented with 0.05% L-cysteine (Sigma, St. Louis, USA)
and 1% w/v of a specific carbohydrate as the sole carbon and
energy source in an anaerobic chamber (Mac 500, Don Whitley
Scientific, West Yorkshire, United Kingdom). E. coli EC101 was
grown at 37uC in Luria Bertani (LB) broth. Where appropriate,
10 mg ml-1 of tetracycline (Tet) or 50 mg ml-1 of kanamycin (Kan)
was added for transposon or plasmid selection. D-Glucose, D-
Galactose, D-Lactose and D-Ribose were purchased from Sigma,
Pullulan was obtained from Hayashibara (Japan) and Vivinal GOS
was from FrieslandCampina (Amersfoort, The Netherlands).
Construction of a Tetracycline Resistant Tn5 Transposon
Extensor Master Mix Polymerase (Thermo Fisher Scientific,
Waltham, Massachusetts) was used for all PCR reactions. A
tetracycline resistance cassette of bifidobacterial origin, tetW [31],
was PCR amplified from pAM5 using the primer pair TetWFw
and TetWRev (Table 1). The amplified product was sequentially
restricted with SphI and XbaI, and ligated into similarly digested
pMOD2 (Epicentre Biotechnologies, Madison, USA), yielding
pMOD2-TetW. Preparation of E. coli electrocompetent cells and
electrotransformation were performed according to previously
described procedures [32]. E. coli transformants were selected on
LB agar plates supplemented with 50 mg ml-1 of kanamycin and
10 mg ml-1 of tetracycline. Presence of the correct construct
among the transformants was verified through restriction mapping
and subsequent sequencing (Eurofins MWG Operon, Ebersberg,
Germany).
Primers pMOD,MCS.Fw and pMOD,MCS.Rev (Table 1)
were used to PCR amplify a TetW-Tn5-encompassing transposon
(EZ::TN,TetW.) from pMOD2-TetW. The transposon encom-
passes tetW and a rho-independent transcriptional terminator,
flanked by the 19 bp terminal ends recognized by the Tn5
transposase [33]. The transcriptional terminator is identical in
sequence to the region located immediately downstream of clpP in
B. breve UCC2003 [34]. Transposon ends were pruned by PshAI
digestion according to manufacturers instructions (Epicentre
Biotechnologies, Madison, USA). Pruned transposon was subse-
quently purified using high pure PCR purification columns
(Roche, West Sussex, United Kingdom), ethanol precipitated
and concentrated to 400 ng ml -1.
Creation of a B. breve UCC2003 Transposon Mutant Bank
B. breve UCC2003 electrocompetent cells were prepared
according to a previously described procedure [35], with the
following minor modifications. The carbohydrates; glucose,
lactose, Vivinal GOS or ribose, were adopted as the main energy
and carbon sources, at 1% w/v final concentration, in the mMRS
broth for the preparation of competent cells.
To prepare the transposome complex: 2 ml of the EZ::TN,-
TetW. transposon were incubated with 4 ml of purified Tn5
transposase (Epicentre Biotechnology, Madison, USA) and 4 ml of
50% (w/v) glycerol to give a total reaction volume of 10 ml in
accordance with the manufacturer’s instructions, to produce
transposition complexes, also called transposomes [36]. 0.2 ml
(20 ng) of the assembled transposome was combined with freshly
prepared electrocompetent cells of B. breve UCC2003 for a single
electroporation experiment. Tet-resistant transformants were
selected on RCA plates supplemented with tetracycline. Resulting
colonies were manually inoculated into individual wells of 96-
microwell plates containing 150 ml of RCM broth supplemented
with tetracycline. Following overnight growth, wells were supple-
mented with glycerol (Sigma, St Louis, USA) to a 20% w/v final
concentration, and plates were stored at 280uC.
To prepare the mutant library of B. breve UCC2003, 32
independent electroporation experiments were performed, pre-
paring competent cells following growth in mMRS broth
supplemented with 0.05% L-cysteine and 1% w/v lactose as the
sole carbon source. Following electroporation cells were recovered
in RCM, containing both glucose and starch as carbon sources,
and incubated anaerobically at 37uC for 30 minutes, which is not
long enough for individual transformants to commence growth on
the recovery medium thus minimizing the chance of isolating
clonal siblings.
Southern Hybridisation Analysis and Determination of
Transposon Insertion Sites
DNA from B. breve UCC2003-derived transposon insertion
mutants was isolated according to previously described procedures
[37]. Southern blot transfer of BstEII digested chromosomal DNA
was performed according to Sambrook et al. [32]. A PCR product
encompassing tetW was used as the hybridisation probe and the
hybridization and detection were performed according to the
protocol of the digoxigenin DNA-labelling and detection kit
(Roche Molecular Biochemicals, Lewes, United Kingdom).
Inverse PCR (i-PCR) reactions were performed to determine
the transposon insertion site in selected tetracycline-resistant B.
breve transformants. Two mg of chromosomal DNA samples were
restricted with BstEII, cleaned by phenol extraction (1:1) and
ethanol precipitated. Amounts of 0.2 and 0.4 mg of the restricted
DNA were self-ligated in a final volume of 50 ml using T4 DNA
Ligase (Promega, Wisconsin, USA). Ligation reactions were
incubated overnight at room temperature. Following ligation,
DNA samples were phenol extracted, ethanol precipitated and
resuspended in 10 ml of distilled water. Half of this sample was
then used as template for the inverse-PCR reactions that were
Transposon Mutagenesis in Bifidobacteria
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performed with the primers i-PCR-Fw and i-PCR-Rev (Table 1).
PCR products were sequenced with the nested primers pMOD-
fw-seq and pMOD-rev-seq (Table 1) to allow determination of the
precise location of a transposon insertion.
Phenotypic Screening and Monitoring of Carbohydrate-
dependent Growth
B. breve UCC2003-Tn5 insertion mutants from 96-well plates
were manually replicated using a 96-pin replicator (Boekel
Scientific, Pennsylvania, USA). Stocked clones from the 280uC
freezer were transferred to fresh microwell plates containing RCM
supplemented with tetracycline (10 mg ml-1) and were incubated
overnight, anaerobically at 37uC. Bacterial mutants were subcul-
tured twice in RCM with tetracycline and subsequently fresh
overnights were spotted onto QTrays (Molecular Devices,
Berkshire, United Kingdom) containing either RCA or mMRS
Agar, supplemented with 0.05% w/v final concentration of L-
cysteine and 0.5% w/v final concentration of D-glucose, D-
lactose, D-galactose or pullulan. The QTrays were incubated
anaerobically at 37uC for 48 hours. Transposon mutants which
grew on RCA but failed to grow in mMRS containing a single
carbohydrate as the sole carbon and energy source were selected
for further analysis.
Carbohydrate-dependent growth of selected mutants was
confirmed through inoculation into liquid mMRS broth contain-
ing 0.5% w/v of the following carbohydrates: D-glucose, D-
lactose, D-galactose or pullulan. Where relevant for comparison,
D-glucose or D-ribose was employed as a positive control for
mutant growth on mMRS-based broth. OD600nm was monitored
during 24 hours of incubation at 37uC under anaerobic conditions.
Subsequent identification of the transposon insertion site in
selected mutants was performed as stated above.
Results
Optimization of Transposition Conditions in B. breve
UCC2003
Since the successful application of the EZ::TN transposome
strategy to generate significant numbers of insertion mutants is
critically dependent on the transformation efficiency of the
competent cells, both transformation efficiencies (following elec-
troporation of a replicative vector, pAM5, isolated from B. breve
UCC2003), and transposition frequencies (following electropora-
tion of 20 ng of EZ::TN transposome) were determined on various
batches of competent cells. Initially, the EZ::TN transposome
strategy was shown to have limited success when the transposition
complexes were introduced by electroporation into B. breve
UCC2003 competent cells freshly prepared according to the
standard procedure based on growth in mMRS broth containing
glucose as the sole carbon source [35]. Under these experimental
conditions the transformation efficiency for pAM5 plasmid DNA
was 86106 CFU mg21 DNA, which is within the range of
previously described values for the same strain [21]. However, the
number of transposon mutants was too low for a practical
application of the EZ::TN system (Table 2); therefore an
optimization of the method to increase the transformation
efficiency and/or the transposition frequency was necessary.
The inclusion of different carbon sources in the growth medium
that was used to prepare the competent cells only slightly modified
the transformation efficiencies obtained, but significantly im-
proved the transposition frequencies (Table 2). In particular, when
electrocompetent cells were prepared from cells that had been
grown in mMRS containing lactose as the sole carbohydrate
source higher amounts of transposon insertion mutants were
obtained per electroporation reaction (up to 1,500 putative
transposon insertion mutants per 20 ng of transposome electro-
Table 1. Strains, plasmids and primers used.
Strains Relevant phenotype or genotype
Reference or
Source
B. breve UCC2003 Infant isolate [37]
B. breve NCFB2258 Infant isolate NCFB
E. coli EC101 Cloning host, repA+, Kanr [59]
Plasmids
pMOD2 Source of tn5 terminal ends, AmpR Epicentre
Biotechnology
pMOD2-TetW TetR derivative of pMOD2 This study
Primers Sequence
TetW-Fw 59-CGCTAGTCTAGAGCTCATGTACGGTAAGGAAG-39 This study
TetW-Rev 59CGCTAGGCATGCAAAACCCTCGGTCGGTCTGACCGGGGGTTTTGATTACATTACCTTCTGAAACATATGGC-39 This study
pMOD,MCS.Fw 59-ATTCAGGCTGCGCAACTGT-39 Epicentre
Biotechnology
pMOD,MCS.Rev 59-GTCAGTGAGCGAGGAAGCGGAAG-39 Epicentre
Biotechnology
i-PCR-Fw 59-GCATACCGTACTGATCTG-39 This study
i-PCR-Rev 59-CAATCATACCGGCTTCC-39 This study
pMOD-fw-seq 59-GCCAACGACTACGCACTAGCC-39 Epicentre
Biotechnology
pMOD-rev-seq 59-GAGCCAATATGCGAGAACACC-39 Epicentre
Biotechnology
Restriction sites are underlined and a rho-transcriptional terminator sequence is highlighted in bold. NCFB, National Collection of Food Bacteria.
doi:10.1371/journal.pone.0064699.t001
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porated in a single electroporation attempt). This transposition
frequency is high enough to routinely perform random mutagen-
esis in bifidobacteria and is significantly higher than the reported
frequencies achieved for this Tn5-based methodology in other
bacteria considered recalcitrant to transformation [38]. Therefore,
lactose was selected as the carbon source to be used to prepare
competent cells to create a comprehensive bank of B. breve
UCC2003 transposon mutants. Utilization of RCM, which
contains both glucose and starch as carbon sources, plus
tetracycline as the transposon mutant selection medium ensured
that mutants defective in lactose metabolism could still be
represented in the bank. The applicability of this transposon
mutagenesis strategy for other bifidobacteria was also tested in a
second strain, namely B. breve NCFB2258, in which a maximum
amount of 700 tetracycline resistant clones was obtained per
electroporation reaction when applying the conditions optimized
for B. breve UCC2003. However, it stills remains to be determined
whether further optimization of the procedure might lead to
increase transposition frequencies in the strain NCFB2258.
Confirmation of Transposition Insertion Events
For confirmation of the expected transposition events in the B.
breve strains, Southern hybridization analyses were performed.
Chromosomal DNA preparations, extracted from randomly
selected transposon-generated, tetracycline-resistant mutants (70
mutants in the case for B. breve UCC2003 and 16 mutants for B.
breve NCFB2258), were BstEII digested, after which Southern
analysis was performed using the tetracycline-resistance gene (tetW)
as a probe. The blots revealed the presence of the transposon, in
single copy, on the chromosome of the selected tetracycline-
resistant transformants (examples are shown in Fig. 1). The size of
hybridizing bands appeared to be different among the majority of
the mutants, suggesting that transposon insertion had occurred at
different positions within the chromosome. Sequencing of inverse-
PCR products and comparison to B. breve UCC2003 genome
information enabled the identification of the transposon insertion
point for a selection of clones. Our sequencing efforts focused on
those hybridizing bands showing apparently similar sizes on the
blots to demonstrate that these represented individual transposon
insertions in different chromosomal locations (corresponding to
lanes A through to R in Fig. 1). The transposon site mapping
experiments confirmed that insertions had occurred at different
positions (Table 3), consistent with random transposon-mediated
mutagenesis. In addition, the presence of insertions located at
different positions within the same gene (Table 3) increase the
probability of finding disruptive mutations for a given gene.
Furthermore, the presence of 9 bp duplications in the chromo-
somal regions flanking the inserted transposon at the identified
target sites, generated following repair of the chromosomal gaps
created during the transposition event, is further evidence of Tn5-
mediated transposition [33], [39].
Creation of a B. breve UCC2003 Transposon Mutant
Library
Comprehensive libraries of random mutants provide a conve-
nient collection of mutants in almost any non-essential gene,
allowing functional screens on a genome-wide scale to be
performed. Ideally, mutants should contain a single insertion
within a given genome, the distribution of the insertions should be
random across the genome and the size of the mutant’s collection
should be large enough to guarantee that every non-essential gene
would be targeted in at least one clone in the collection [40].
Therefore, in view of the transposition frequencies achieved in
strain B. breve UCC2003, the conditions optimized in the above
examinations were employed to create a bank of random mutants
in B. breve UCC2003, which comprised of approximately 20,000
transposon insertion mutants. In a simplified model, assuming that
the transposon is randomly inserted and that all the genes have the
same probability of being the target of a mutation, the probability
of finding a mutation within a particular gene might be defined as
P = 1-(1-X/G)n, where P is the probability of finding a mutation
within a particular gene, X is the average length of the genes, G is
the genome length and n is the number of clones within the library
[41]. Therefore, based on B. breve UCC2003 genome information
[18], the probability of finding a mutation within a given gene in
our mutant library is 99.99%. This formula does not take into
consideration the presence of essential genes on a bacterial
genome for which a viable mutant would never be recovered, or
indeed the occurrence of genes as part of operons, in which any
insertion would inactivate all genes located downstream in the
same operon. Thus, the realistic probability of finding at least one
mutant carrying a mutation in a non-essential gene of B. breve
UCC2003 in our mutant bank is likely to be very close to 100%.
Screening for Defective Growth in Selected Carbon
Sources, Identification of Transposon Insertion Sites and
Phenotypic Confirmation
Comprehensiveness of the B. breve UCC2003 transposon mutant
library was tested by conducting a phenotypic screen to identify
clones defective for growth on particular carbon sources (D-
lactose, D-galactose and pullulan). A total number of 3,744
mutants from the mutant library were screened for an inability to
grow on mMRS when supplemented with a particular carbon
source (agar plates containing 0.5% w/v of lactose, galactose, or
pullulan). This phenotypic screening was followed by validation of
the observed growth deficiency of selected clones into liquid
mMRS broth supplemented with the corresponding carbon
source. The transposon insertion site was determined for five
mutants, which exhibited a particular phenotype of failing to grow
in mMRS supplemented with one or more of the tested
carbohydrates in both agar and broth assays (Fig. 2, Table 3).
From those, one mutant, designated 101C6, showed absence of
growth as determined by final OD600 after 24 hours of incubation
on lactose (Fig. 2 I). Mutant 101C6 was shown to harbor the
transposon within a gene (Bbr_0010) encoding one of the
previously identified b-galactosidases in B. breve UCC2003
(Table 2, Fig. 3) [42]. Our data therefore indicates that the b-
galactosidase encoded by Bbr_0010 is the main b-galactosidase
Table 2. Transformation efficiencies and transposition
frequencies.
Sugar
Transformation
Efficiency* Transposition Events*
Glucose 8.246106 160.00
GOS 1.476107 38614.14
Ribose 1.26107 198619.80
Lactose 1.386107 15546192.33
Ribose+Lactose 2.196107 9866123.04
*Transformation efficiencies and transposition frequencies were determined
following electroporation of a replicative vector, namely pAM5, or a
tetracycline-resistant TN5 transposome, respectively, into B. breve UCC2003
competent cells grown in different carbohydrates. Transposition events are
average of independent duplicates.
doi:10.1371/journal.pone.0064699.t002
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Figure 1. Confirmation of transposon insertion events into B. breve UCC2003 and B. breve NCFB2258 genome by Southern
hybridization. Blots of twenty-six randomly selected mutants of B. breve UCC2003 (Panel I, two blots) and sixteen randomly selected mutants of B.
breve NCFB2258 (Panel II, single blot) are shown. Lanes labeled from A to R correspond to mutants whose insertion site was subsequently sequenced
as indicated in Table 3.
doi:10.1371/journal.pone.0064699.g001
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employed by this bacterium to metabolize lactose, at least under
the conditions tested.
Two mutants, namely 181D10 (Fig. 2 II) and 163D6, which
showed impaired growth on lactose and absence of growth in
galactose, were found to harbor the transposon inserted within a
predicted homolog of the galT gene (Bbr_0491) (Table 2, Fig. 3).
This gene is predicted to encode the enzyme that catalyzes the
second step of the Leloir pathway, converting D-galactose into
UDP-glucose, which would subsequently be fed into the bifid
shunt [43], [44]. Accordingly, these mutants also showed reduced
growth abilities on D-lactose which is expected to be due to their
inability to metabolize the galactose component of the disaccha-
ride lactose.
Finally, two mutants, 164B7 (Fig. 2 III) and 101C4, were
identified to be deficient in growth on the polysaccharide pullulan.
In both mutants the transposon insertion was mapped to different
positions within the same gene (Bbr_0121), encoding a component
of a predicted maltodextrin ABC-type transporter, and located
upstream of the previously described amylopullulanase-encoding
gene Bbr_0123 (Table 2, Fig. 3) [45]. The product encoded by this
gene is predicted to be involved in the uptake of the maltodextrins
cleaved as a result of amylopullulanase activity on pullulan in the
extracellular environment. Finally, it is worth noting that all
mutants discussed above were shown to grow equally well as their
wild type UCC2003 derivative on mMRS supplemented with
either ribose (Fig. 2) or glucose (results not shown).
Table 3. Mapping transposon insertion sites in a random selection of transposon insertion mutants.
Clone ID Point of insertion 9bp duplication Gene Predicted Function
B. breve UCC2003
A 409756 ctgcagggc Bbr_0296 Alpha-amylase family protein
B 2084087 ccgcatgcc Bbr_1690 ebgA-Evolved beta-galactosidase a-subunit
C 1884781 gcctgggcg Bbr_1512 Transposase
D 1802786 catcgcagg Bbr_1445 Activator of (R )-2-hydroxylglutarylCoA dehydratase
E 492623 cagttaccg Bbr_0366 Conserv. Hypothetical secreted protein
F 1527997 gtacacgac Bbr_1222 Phosphohydrolase (MuT/nudx fam prot)
G 1719332 ccccggagg Bbr_1383 Conserv. Hypothetical protein with DUF domain
H 502520 gccgacgtc Bbr_0375 Conserv. Hypothetical membrane spanning protein
I 633832 cccgatgac Bbr_0482 Conserv. Hypothetical protein
J 1771618 gatgaggtt - 223 nt upstream Bbr_1420
K 634533 gttcacgcg Bbr_0482 Conserv. Hypothetical protein
UCC1 1167747 gataagaag Bbr_0915 Conserv. Hypothetical protein with DUF558 domain
UCC3 325241 ggtctgtgt Bbr_0230 Phage infection protein pip2
UCC6 15851 agaccactg - intergenic region Bbr_0010-Bbr_0011
UCCIE1 1643659 cctctaccg Bbr_1316 Transporter, MFS Superfamily
UCCIE12 590969 gttttacgc Bbr_0444 Membrane spanning polysaccharide biosynthesis protein
UCCIF6 2090095 accttgaaa Bbr_1693 Glycosyl hydrolases family 65, Kojibiose phosphorylase
UCCIF12 1022428 ccggaagcc Bbr_0787 pfl Formate acetyltransferase
UCCIH12 850699 cgttggtag Bbr_0651 Conserved hypothetical secreted protein
UCCIIC1 1795092 gaacaagcc Bbr_1442 bgl2 Beta-glucosidase
UCCIIE8 1349191 gtacgacgt Bbr_1084 Conserved hypothetical protein with helix-turn-helix motif
B. breve UCC2003 selected following carbohydrate-utilization screening
101C6 14835 gctgaggcc Bbr_0010 lacZ1 Beta-galactosidase
163D6 647753 gtgtcccgc Bbr_0491 galT1Galactose-1-phosphate uridylyltransferase
181D10 648238 gccgtacat Bbr_0491 galT1 Galactose-1-phosphate uridylyltransferase
101C4 181945 acttcctga Bbr_0121 Conserved hypothetical membrane spanning protein
164B7 182029 tggccttcc Bbr_0121 Conserved hypothetical membrane spanning protein
B. breve NCFB2258 clones
L - cagggccac - Transcriptional regulator LacI family
M - tcggtgaac - Homolog to Maf protein
N - gggatgtgg - Beta-glucosidase
O - gtgtagaga - Permease protein of ABC transporter for sugars
P - gcccagaac - Permease protein of ABC transporter for metals
Q - ggccgccac - Conserved hypothetical protein
R - aggccaccg - Homolog to ABC transporter, ATP binding component
doi:10.1371/journal.pone.0064699.t003
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Discussion
The expanding collection of complete Bifidobacterium genomes
coupled to extensive efforts to expand the molecular toolbox for
this group of bacteria, are contributing to make bifidobacteria
more accessible to genetic manipulation [46], [47]. However, only
a few targeted mutations have been reported in certain strains
[22], [45], [48], [49] and no systems for random mutagenesis in
bifidobacteria have yet been described. In this work a B. breve
UCC2003 TN5 insertion library consisting of nearly 20,000
mutants was created based on the EZ::TN transposome system.
Further analysis of randomly selected clones as well as analysis of
clones selected following a screening for the inability to grow on
certain carbohydrates, has validated the library since the
transposon insertions were proved to be single and apparently
random. This transposon mutagenesis strategy was also successful
in a second strain of B. breve and may thus be applicable to other
bifidobacterial strains and species, provided that high transforma-
tion efficiencies and antibiotic selection markers are available.
Transposon mutagenesis systems have been extensively em-
ployed in Gram negative bacteria and more recently, also in Gram
positives, including certain Actinobacteria [50], [51], [52].
However, implementation of in vivo transposon delivery systems
generally requires conditional origins of replication and efficient
determinants to control the transposase expression, which are not
readily available for most Bifidobacterium strains [47]. The EZ::TN
Transposome system, based on the in vitro assembly of stable
complexes between a purified transposase and a transposon which
are directly introduced into the host by electroporation, bypasses
some of these limitations [36]. Furthermore, this system has been
successfully implemented for a wide range of bacteria, including a
significant number of Actinobacteria [53], [54], [55], [56], [57].
Low transformation efficiencies, endogenous restriction endonu-
cleases and the efficient expression of the selection marker within
the transposon, are the main bottlenecks for the effectiveness of the
EZ::TN Transposome system [58]. In this work, the use of a
selection marker of bifidobacterial origin, tetW [31], which doesn’t
harbor the restriction sites that B. breve UCC2003 cleaves [21],
allowed us to create the first transposon insertion mutants in
bifidobacteria. In addition, optimization of competent cell
preparation resulted in transposition frequencies high enough to
routinely perform transposon-based random mutagenesis in B.
breve UCC2003 (Table 2). The transposition frequency values
obtained in this work for bifidobacteria are within the same range
as those obtained for other bacteria including Rhodococcus [50] or
Mycobacterium [55], although transformation efficiencies reported
for bifidobacteria are still lower than those reported for other
bacteria. Remarkably, transformation efficiencies reported in
Lactobacillus casei were 10-fold higher than values achieved in B.
breve UCC2003 although transposition frequencies were around
Figure 2. Growth profiles of B. breve UCC2003 and derived transposon mutant strains, 101C6 (I), 181D10 (II) on lactose, galactose
and ribose; and 164B7 (III) on lactose, pullulan and ribose. Presented data are average of duplicate independent growth experiments.
doi:10.1371/journal.pone.0064699.g002
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10-fold lower [38]. This suggests that further optimization of
competent cells preparation in other bacteria may allow dramatic
increases in transposition efficiencies as demonstrated in this work
for bifidobacteria. However, the effect of host-encoded restriction
endonucleases and differential efficiencies on expression of
selective markers cannot be ruled out when performing transposon
mutagenesis with this transposome strategy into new strains.
Further knowledge on specific host-encoded restriction endonu-
cleases will undoubtedly facilitate transposon design for additional
bifidobacterial species/strains.
In this work the generated mutant library for B. breve UCC2003
represents an estimated average coverage of,10 insertions per gene.
The size of this bank is within the range of other bacterial mutant
collections and is thus presumed to contain insertions in the vast
majority of non-essential genes of B. breve UCC2003. Therefore, a
phenotypic screening was conducted to confirm the usefulness of this
Bifidobacterium collection of mutants to perform functional genomic
analysis. Utilization of different carbohydrates was selected as a
proof-of-principle screening due to the large amount of information
that extensive research on this topic has revealed inB. breveUCC2003
over the past few years [44]. Although only ,20% of the mutants
present in the bank were screened, clones showing inability to grow
were found for the three tested carbohydrates. In addition, a number
of mutants were identified that harbour insertions at different
positions within the same gene, thus confirming that multiple,
independent insertions per gene are present in the mutant bank.
Therefore, this is expected to increase the probability of finding
insertions within a given gene, at positions sufficiently disruptive to
cause phenotypic alterations. Furthermore, the identified transposon
insertion sites of analyzed mutants could be correlated with the
observed phenotypes, demonstrating the usefulness of this mutant
library for functional screenings. However, one has to keep in mind
that polar effects of the inserted transposon on downstream-located
genes within a single transcriptional unit cannot be excluded and
complementation experiments will be necessary to ascertain whether
an interruptedgene isdirectly responsible foranobservedphenotype.
Inconclusion, the first libraryofrandommutantsofaBifidobacterium
strain was obtained. Preliminary analysis of transposon insertion
mutants and a proof-of-principle screening, led us to validate the
usefulness of the bank to perform efficient genome-wide screenings.
The transposon mutagenesis system was also successfully applied to a
secondB. breve strain; however, further research is needed in order to
establish if this mutagenesis tool can be extended to other
bifidobacterial strains that currently seem to berecalcitrant to genetic
manipulation. Construction and optimization of a second generation
TN5-TetW-based transposon system aimed at tracking mutants
withinpoolsor in vivomodelswill further facilitate functionalgenomic
efforts in bifidobacteria including the elucidation of molecular
mechanisms of probiotic action.
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